ClearPoint Neuro (CLPT) Common Equity (2011 - 2026)
ClearPoint Neuro recorded quarterly Common Equity of $18.8 million in Q1 2026, down 32.76% quarter-over-quarter from $28.0 million in Q4 2025, and down 5.73% year-over-year from $20.0 million in Q1 2025.
ClearPoint Neuro's Common Equity history runs 16 years deep, the most recent figure standing at $18.8 million for Q1 2026.
- In Q1 2026, Common Equity fell 5.73% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (down 5.73% YoY), while the FY2025 annual figure was $28.0 million, up 10.36% from the prior year.
- Common Equity came in at $18.8 million for Q1 2026 at ClearPoint Neuro, down from $28.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $45.7 million in Q1 2022 to a low of $15.9 million in Q3 2025.
- A 5-year average of $29.1 million and a median of $28.0 million in 2025 frame the typical range for Common Equity.
- Across the five-year window, Common Equity grew 20.37% in 2024 and tumbled 45.26% in 2025, its largest moves.
- ClearPoint Neuro's Common Equity stood at $36.9 million in 2022, then sank by 42.6% to $21.2 million in 2023, then grew by 19.91% to $25.4 million in 2024, then increased by 10.36% to $28.0 million in 2025, then sank by 32.76% to $18.8 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $18.8 million, $28.0 million, and $15.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 18.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.84 Mn |
| Dec 31, 2025 | 28.02 Mn |
| Sep 30, 2025 | 15.87 Mn |
| Jun 30, 2025 | 19.74 Mn |
| Mar 31, 2025 | 19.99 Mn |
| Dec 31, 2024 | 25.39 Mn |
| Sep 30, 2024 | 29.00 Mn |
| Jun 30, 2024 | 32.13 Mn |
| Mar 31, 2024 | 34.58 Mn |
| Dec 31, 2023 | 21.17 Mn |
| Sep 30, 2023 | 24.09 Mn |
| Jun 30, 2023 | 27.41 Mn |
| Mar 31, 2023 | 32.58 Mn |
| Dec 31, 2022 | 36.89 Mn |
| Sep 30, 2022 | 39.88 Mn |
| Jun 30, 2022 | 42.82 Mn |
| Mar 31, 2022 | 45.73 Mn |
| Dec 31, 2021 | 48.79 Mn |
| Sep 30, 2021 | 44.12 Mn |
| Jun 30, 2021 | 47.97 Mn |
| Mar 31, 2021 | 43.98 Mn |
| Dec 31, 2020 | 2.38 Mn |
| Sep 30, 2020 | 149,000.00 |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 2.76 Mn |
| Dec 31, 2019 | 4.59 Mn |
| Sep 30, 2019 | 6.01 Mn |
| Jun 30, 2019 | 6.91 Mn |
| Mar 31, 2019 | 442,619.00 |
| Dec 31, 2018 | 1.51 Mn |
| Sep 30, 2018 | 2.49 Mn |
| Jun 30, 2018 | 3.56 Mn |
| Mar 31, 2018 | 4.75 Mn |
| Dec 31, 2017 | 5.83 Mn |
| Dec 31, 2016 | -756,069.00 |
| Sep 30, 2016 | 574,585.00 |
| Jun 30, 2016 | -3.96 Mn |
| Mar 31, 2016 | -3.61 Mn |
| Dec 31, 2015 | -1.98 Mn |
| Sep 30, 2015 | -5.82 Mn |
| Jun 30, 2015 | -5.88 Mn |
| Mar 31, 2015 | -3.63 Mn |
| Dec 31, 2014 | -100,330.00 |
| Sep 30, 2014 | -7.93 Mn |
| Jun 30, 2014 | -4.51 Mn |
| Mar 31, 2014 | -3.14 Mn |
| Dec 31, 2013 | -6.83 Mn |
| Sep 30, 2013 | -5.61 Mn |
| Jun 30, 2013 | -2.82 Mn |
| Mar 31, 2013 | -1.87 Mn |
| Dec 31, 2012 | -7.87 Mn |
| Sep 30, 2012 | -9.42 Mn |
| Jun 30, 2012 | -10.73 Mn |
| Mar 31, 2012 | -12.70 Mn |
| Dec 31, 2011 | -21.84 Mn |